Adenosine uptake inhibitors

European Journal of Pharmacology
Tohru NojiHideaki Kusaka

Abstract

Adenosine is a purine nucleoside and modulates a variety of physiological functions by interacting with cell-surface adenosine receptors. Under several adverse conditions, including ischemia, trauma, stress, seizures and inflammation, extracellular levels of adenosine are increased due to increased energy demands and ATP metabolism. Increased adenosine could protect against excessive cellular damage and organ dysfunction. Indeed, several protective effects of adenosine have been widely reported (e.g., amelioration of ischemic heart and brain injury, seizures and inflammation). However, the effects of adenosine itself are insufficient because extracellular adenosine is rapidly taken up into adjacent cells and subsequently metabolized. Adenosine uptake inhibitors (nucleoside transport inhibitors) could retard the disappearance of adenosine from the extracellular space by blocking adenosine uptake into cells. Therefore, it is expected that adenosine uptake inhibitors will have protective effects in various diseases, by elevating extracellular adenosine levels. Protective or ameliorating effects of adenosine uptake inhibitors in ischemic cardiac and cerebral injury, organ transplantation, seizures, thrombosis, insomnia, pain, and i...Continue Reading

References

Mar 1, 1992·Circulation·S W Ely, R M Berne
Mar 1, 1992·Journal of Molecular and Cellular Cardiology·J P HeadrickR M Berne
Jan 1, 1992·Fundamental & Clinical Pharmacology·B B FredholmF Parkinson
Aug 1, 1992·Anesthesiology·T MöllhoffW Flameng
Oct 1, 1991·The Journal of Pharmacy and Pharmacology·P K YeungG A Klassen
Feb 7, 1992·Journal of Medicinal Chemistry·K A JacobsonM Williams
Apr 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·H P BaerH Van Belle
Jun 1, 1991·Neuropharmacology·S D O'ConnorM Radulovacki
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T C Chan, S B Howell
May 1, 1990·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·T S Park, J M Gidday
Aug 1, 1989·Journal of Molecular and Cellular Cardiology·H Van BelleJ Wynants
Aug 1, 1986·British Journal of Pharmacology·J SawynokT D White
Sep 1, 1988·Stroke; a Journal of Cerebral Circulation·D K von LubitzD J Redmond
Sep 1, 1986·The Journal of Clinical Investigation·B N CronsteinR Hirschhorn
Nov 1, 1985·Journal of Cellular Physiology·P G PlagemannM Kraupp
Jan 21, 1985·Life Sciences·A Verma, P J Marangos
Jan 1, 1984·Pharmacology·J Q QianP A van Zwieten
Jan 1, 1983·Thrombosis Research. Supplement·L A Harker, R A Kadatz
Jul 1, 1982·Journal of Neurochemistry·P J MarangosA M Martino
Jan 1, 1980·The International Journal of Biochemistry·H OsswaldH Hermes
Nov 1, 1994·Journal of Cardiovascular Pharmacology·M ItoyaO Iimura
Apr 1, 1995·Journal of Molecular and Cellular Cardiology·K Mullane, D Bullough
Jan 1, 1995·Annual Review of Medicine·J H Southard, F O Belzer

❮ Previous
Next ❯

Citations

Nov 21, 2007·Inflammatory Bowel Diseases·Luca AntonioliCorrado Blandizzi
Apr 12, 2008·Purinergic Signalling·Andreas DeussenAnnette Pexa
Nov 26, 2010·Purinergic Signalling·Mark WallNicholas Dale
Apr 2, 2011·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·German ReyesImogen R Coe
Feb 24, 2012·Journal of Neurophysiology·J M HawrylukE Arrigoni
May 1, 2009·Future Medicinal Chemistry·Meryem Köse, Anke C Schiedel
Jun 7, 2014·Pharmacological Reports : PR·Mariusz J ŚwiąderJarogniew J Łuszczki
Oct 27, 2009·Neurochemical Research·Zsolt KovácsKatalin A Kékesi
May 20, 2009·Scandinavian Journal of Clinical and Laboratory Investigation·Sule PoturogluZeynel Mungan
Mar 10, 2007·The Journal of Physiology·Mark J Wall, Nicholas Dale
Apr 21, 2007·The Journal of Physiology·Mark J WallNicholas Dale
Aug 5, 2009·The Journal of Physiology·Alison Atterbury, Mark J Wall
May 26, 2009·European Journal of Pharmacology·Vijay Kumar, Ambika Sharma
Oct 14, 2008·Pharmacology & Therapeutics·Luca AntonioliCorrado Blandizzi
Nov 26, 2015·Life Sciences·Nehal M ElsherbinyKhaled H Abd El Galil
Jan 16, 2008·Journal of Neurochemistry·Sylvia Cechova, B Jill Venton
May 28, 2011·British Journal of Pharmacology·M G ZizzoR Serio
Nov 20, 2015·Neuropharmacology·Felicita PedataAnna Maria Pugliese
Sep 1, 2015·Pharmacological Reports : PR·Iwona Pelikant-MaleckaEwa M Slominska
Apr 12, 2017·The Journal of Pharmacy and Pharmacology·Jan Schmidt, Polonca Ferk
Jul 3, 2015·Therapeutic Advances in Chronic Disease·Nicholas B Norgard, James J DiNicolantonio
Jun 16, 2017·Journal of Cellular Physiology·Amirhossein BahreyniSeyed M Hassanian
Apr 6, 2018·Annual Review of Neuroscience·Ragnhildur T Káradóttir, Chay T Kuo
Jan 27, 2011·Journal of Cardiovascular Pharmacology·Rachel W S LiGeorge P H Leung
May 1, 2010·The Journal of Biological Chemistry·Isadora Susan DanielsCheng Chi Lee
Jul 19, 2018·American Journal of Physiology. Cell Physiology·Daniel JungHatim Hassan
Sep 10, 2020·ImmunoTargets and Therapy·Nadia PeyravianJoaquin J Jimenez
Jul 31, 2013·Journal of Thrombosis and Haemostasis : JTH·S NylanderM Cattaneo
Nov 24, 2020·Chemické Zvesti·Helena D Janse van RensburgGisella Terre'Blanche
Oct 16, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Barbara Kutryb-ZajacRyszard T Smolenski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Basal Forebrain & Food Avoidance

Neurons in the basal forebrain play specific roles in regulating feeding. Here are the latest discoveries pertaining to the basal forebrain and food avoidance.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.